Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Ocrelizumab bij relapsing en primair progressieve MS
jan 2017 | Multipele Sclerose